These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. White matter abnormalities associated with auditory hallucinations in schizophrenia: a combined study of voxel-based analyses of diffusion tensor imaging and structural magnetic resonance imaging. Seok JH; Park HJ; Chun JW; Lee SK; Cho HS; Kwon JS; Kim JJ Psychiatry Res; 2007 Nov; 156(2):93-104. PubMed ID: 17884391 [TBL] [Abstract][Full Text] [Related]
24. [Is late-onset schizophrenia related to neurodegenerative processes? A review of literature]. Lagodka A; Robert P Encephale; 2009 Sep; 35(4):386-93. PubMed ID: 19748376 [TBL] [Abstract][Full Text] [Related]
25. Functional dysconnectivity of the dorsolateral prefrontal cortex in first-episode schizophrenia using resting-state fMRI. Zhou Y; Liang M; Jiang T; Tian L; Liu Y; Liu Z; Liu H; Kuang F Neurosci Lett; 2007 May; 417(3):297-302. PubMed ID: 17399900 [TBL] [Abstract][Full Text] [Related]
26. Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment. Chua SE; Deng Y; Chen EY; Law CW; Chiu CP; Cheung C; Wong JC; Lienenkaëmper N; Cheung V; Suckling J; McAlonan GM Psychol Med; 2009 May; 39(5):793-800. PubMed ID: 18713487 [TBL] [Abstract][Full Text] [Related]
27. JMRI special issue: clinical potential of brain mapping using MRI. Leon Partain C J Magn Reson Imaging; 2006 Jun; 23(6):785-6. PubMed ID: 16649198 [No Abstract] [Full Text] [Related]
28. Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls. Witthaus H; Kaufmann C; Bohner G; Ozgürdal S; Gudlowski Y; Gallinat J; Ruhrmann S; Brüne M; Heinz A; Klingebiel R; Juckel G Psychiatry Res; 2009 Sep; 173(3):163-9. PubMed ID: 19616415 [TBL] [Abstract][Full Text] [Related]
29. Differential brain activation during facial emotion discrimination in first-episode schizophrenia. Reske M; Habel U; Kellermann T; Backes V; Jon Shah N; von Wilmsdorff M; Gaebel W; Zilles K; Schneider F J Psychiatr Res; 2009 Mar; 43(6):592-9. PubMed ID: 19056093 [TBL] [Abstract][Full Text] [Related]
30. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Glenthoj A; Glenthoj BY; Mackeprang T; Pagsberg AK; Hemmingsen RP; Jernigan TL; Baaré WF Psychiatry Res; 2007 Apr; 154(3):199-208. PubMed ID: 17360162 [TBL] [Abstract][Full Text] [Related]
31. Volumes of brain, grey and white matter and cerebrospinal fluid in schizophrenia in the Northern Finland 1966 Birth Cohort: an epidemiological approach to analysis. Tanskanen P; Haapea M; Veijola J; Miettunen J; Järvelin MR; Pyhtinen J; Jones PB; Isohanni M Psychiatry Res; 2009 Nov; 174(2):116-20. PubMed ID: 19853416 [TBL] [Abstract][Full Text] [Related]
32. The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. Vita A; De Peri L Int Rev Psychiatry; 2007 Aug; 19(4):429-36. PubMed ID: 17671875 [TBL] [Abstract][Full Text] [Related]
33. Perfusion magnetic resonance imaging in psychiatry. Théberge J Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433 [TBL] [Abstract][Full Text] [Related]
34. Role of functional imaging in neurological disorders. Weiller C; May A; Sach M; Buhmann C; Rijntjes M J Magn Reson Imaging; 2006 Jun; 23(6):840-50. PubMed ID: 16649207 [TBL] [Abstract][Full Text] [Related]
36. Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task. Karch S; Leicht G; Giegling I; Lutz J; Kunz J; Buselmeier M; Hey P; Spörl A; Jäger L; Meindl T; Pogarell O; Möller HJ; Hegerl U; Rujescu D; Mulert C J Psychiatr Res; 2009 Oct; 43(15):1185-94. PubMed ID: 19426993 [TBL] [Abstract][Full Text] [Related]
37. [First and second generation antipsychotics and morphological and neurochemical brain changes in schizophrenia. Review of magnetic resonance imaging and proton spectroscopy findings]. Szulc A Psychiatr Pol; 2007; 41(3):329-38. PubMed ID: 17900049 [TBL] [Abstract][Full Text] [Related]
38. First-episode schizophrenia. A window of opportunity for optimizing care and outcomes. Buckley PE; Evans D Postgrad Med; 2006 Sep; Spec No():5-19. PubMed ID: 17128657 [TBL] [Abstract][Full Text] [Related]
39. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study. Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880 [TBL] [Abstract][Full Text] [Related]
40. Longitudinal changes in neuroanatomy and neural activity in early schizophrenia. Whitford TJ; Farrow TF; Rennie CJ; Grieve SM; Gomes L; Brennan J; Harris AW; Williams LM Neuroreport; 2007 Mar; 18(5):435-9. PubMed ID: 17496799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]